Table 3.

The associations among high IFN levels and SLE manifestations (stratified analyses of nominal regression models)

The analysis was run on 248 patients, in whom all four IFN measurements were available

NPSLE neuropsychiatric SLE, LN lupus nephritis, ESR erythrocyte sedimentation rate, Hb haemoglobin, WBC white blood cells, PLT platelets, AVE any vascular event, aCL anti-cardiolipin, B2GP1 beta 2 glycoprotein 1, LA lupus anticoagulants, aPL antiphospholipid abs, U-alb/krea urine albumin kreatinine ratio

*Definition by Systemic Lupus Activity Measure (SLAM)

^□Definition by SLE Disease Activity Index (SLEDAI)

^{^}Definition by 1982 ACR SLE classification criteria, if ever observed, disease damage was defined by SLE disease damage index (SDI)

^°p values based on Wald test